Conditions: Healthy Volunteers
Keywords: Bio-equivalence Linezolid OS Linezolid tablet
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 20
Healthy volunteers: yes

Brief summary:
The purpose of this study is to estimate the bioequivalence comparing Linezolid 600 MG Oral Suspension with 600 MG tablet in Chinese healthy male subjects. This study data will be used to support Linezolid OS NDA in China.

Detailed description:
To support Linezolid NDA in China.

Arms:
arm 1: Subjects will accept Linezolid OS 600 MG first, after 4 days wash-out, then will accept Linezolid tablet 600 MG. arm 2: Subjects will accept Linezolid tablet 600 MG first, after 4 days wash-out, then will accept Linezolid OS 600 MG.

Interventions: intervention 1: Linezolid intervention 2: Linezolid
Intervention descriptions: intervention 1: 1. Linezolid OS 600 MG
2. Linezolid Tablet 600 MG intervention 2: 1. Linezolid Tablet 600 MG
2. Linezolid OS 600 MG

Protocol document: